Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label doxazosin extended-release study for PTSD-related sleep disturbance
NL-OMON28526Phase 3Recruiting
- Sponsor
- Parnassia Groep
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxazosin in post-traumatic stress disorder (PTSD), sponsored by Parnassia Groep. Primary endpoints: Clinician-Administered PTSD Scale sleep items, Total sleep time and 1 more. Started Apr 2013; status: recruiting.
02
Drugs
doxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON28526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28526.